CRIS Current Research Information System

ZERBINI, MARIALUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.497
AS - Asia 4.674
EU - Europa 4.648
AF - Africa 296
SA - Sud America 199
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.449
CN - Cina 1.557
SG - Singapore 1.322
GB - Regno Unito 1.293
VN - Vietnam 898
DE - Germania 617
UA - Ucraina 579
IT - Italia 577
SE - Svezia 528
HK - Hong Kong 325
IN - India 285
RU - Federazione Russa 280
FR - Francia 205
IE - Irlanda 171
BR - Brasile 146
JP - Giappone 113
ZA - Sudafrica 94
CH - Svizzera 89
EE - Estonia 84
KR - Corea 81
TG - Togo 72
SC - Seychelles 49
NL - Olanda 48
CI - Costa d'Avorio 44
BG - Bulgaria 42
BE - Belgio 35
CA - Canada 34
IR - Iran 32
NG - Nigeria 28
FI - Finlandia 23
AR - Argentina 22
GR - Grecia 19
AT - Austria 16
RO - Romania 12
JO - Giordania 11
UZ - Uzbekistan 10
EC - Ecuador 9
ID - Indonesia 8
PL - Polonia 8
MX - Messico 7
CO - Colombia 6
LB - Libano 6
PY - Paraguay 6
ES - Italia 5
AU - Australia 4
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
MY - Malesia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
UY - Uruguay 2
BO - Bolivia 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
HN - Honduras 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SM - San Marino 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 15.322
Salva come PNG Salva come JPEG
Città #
Southend 1.100
Singapore 804
Ashburn 567
Chandler 540
Fairfield 458
Dong Ket 448
Jacksonville 404
Hong Kong 323
Hefei 289
Wilmington 244
Ann Arbor 243
Seattle 240
Princeton 239
Woodbridge 232
Houston 221
Beijing 178
Dublin 169
Boardman 161
Cambridge 156
Padova 115
Westminster 115
Tokyo 113
Nanjing 109
Santa Clara 104
Ho Chi Minh City 96
Berlin 85
Seoul 81
Los Angeles 79
Bern 78
Medford 73
Lomé 72
Buffalo 71
Hanoi 70
Mülheim 69
Milan 63
Saint Petersburg 63
Shenyang 57
New York 54
Jinan 51
Mahé 47
Abidjan 44
Sofia 42
Changsha 39
Tianjin 39
Bengaluru 38
Bologna 38
Redwood City 37
Nanchang 36
Brussels 35
Dallas 32
Hebei 31
Shanghai 29
Zhengzhou 28
Abeokuta 27
Florence 26
Guangzhou 26
San Diego 25
Verona 25
Bremen 24
Des Moines 23
Jiaxing 22
Hangzhou 21
Helsinki 21
Olalla 18
Taizhou 18
Toronto 18
Frankfurt am Main 17
Haiphong 17
Paris 17
San Venanzo 17
Norwalk 16
Ningbo 14
Shijiazhuang 13
Yubileyny 13
Haikou 12
Phoenix 12
Redondo Beach 12
São Paulo 12
Taiyuan 12
Amman 11
Falkenstein 11
Falls Church 11
Kuban 11
Pune 11
Wuhan 11
Curitiba 10
London 10
Mountain View 10
Rio de Janeiro 10
Rome 10
Turin 10
Vienna 10
Ardabil 9
Kunming 9
Chengdu 8
Chicago 8
Chongqing 8
Dearborn 8
Lanzhou 8
Monmouth Junction 8
Totale 9.829
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 228
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 219
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 199
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 194
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 190
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 188
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 185
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 183
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 182
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 182
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 179
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 178
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 176
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 175
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 174
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 174
Analysis of HPV16 E6*I-II transcripts in cervical samples 174
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 173
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 173
A proteomic approach to the analysis of B19 capsid proteins 169
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 164
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 163
Recurrent erythema in patients with long-term parvovirus B19 infection 162
Analisi della competenza funzionale di cloni genomici di parvovirus B19 159
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 158
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 158
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 157
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 157
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 156
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 152
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 152
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 151
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 150
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 150
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 149
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 149
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 147
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 147
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 146
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 145
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 144
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 143
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 141
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 141
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 140
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 140
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 140
Analysis of the functional competence of genomic clones of Parvovirus B19 137
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 136
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 136
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 136
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 136
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 136
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 134
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 134
Parvovirus B19-derived fetal complications following gestational infection. 133
Evidence of human bocavirus viremia in healthy blood donors. 133
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 132
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 131
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 131
Diagnosi virologica di infezione da papillomavirus umani 129
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 129
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 128
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 128
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 127
Implicazioni nella progressione della patologia cervicale 126
Human papillomavirus in melanoma: reply from authors 126
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 125
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 123
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 122
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 122
High-throughput type-specific detection of HPV using MassARRAY technology 121
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 120
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 119
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 118
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 118
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 118
La biologia molecolare nella diagnosi delle infezioni da HPV 117
B19 parvovirus infections: diagnostic technologies 117
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 117
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 117
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 116
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 116
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 116
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 114
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 114
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 113
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 112
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 110
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 110
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 109
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 104
Detection of parvovirus B19 IgG: choice of antigens and serological tests 103
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 102
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 102
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 95
Construction and functional analysis of B19 genomic clones 94
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 94
Transduction activity and properties of genomic and subgenomic clones of parvovirus B19 92
B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines – a quantitative analysis by real-time PCR 91
Totale 14.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.079
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.311 0 0 0 0 0 119 32 101 125 97 105 732
2021/20222.085 140 105 142 226 177 107 25 112 62 215 358 416
2022/20232.233 251 328 120 269 159 140 61 124 349 36 225 171
2023/2024807 38 96 40 131 47 161 114 70 19 34 17 40
2024/20251.975 73 333 211 134 278 104 221 52 17 61 52 439
2025/20262.585 337 594 495 420 581 158 0 0 0 0 0 0
Totale 15.561